- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04283045
Community-based Adaptive Autism Intervention for Toddlers (CAIT)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study will use a Sequential Multiple Assignment Randomized Trial (SMART) design to assess when to examine initial response to treatment, as well as whether and how best to augment the current first line, standard of care intervention for children demonstrating a slower response.
First, at program entry, the investigators will assess all toddlers using both standardized and experimental assessments as they enroll in the NYCIT program. After entry assessments, the investigators will randomize each child with equal probability to early response assessment at either six weeks or 12 weeks (timing). This early response assessment will be used to determine whether children are considered fast or slow responders to treatment. Children who are considered early responders will continue to receive JASPER. Children responding slowly to the initial intervention will be randomized to continue JASPER or to add JASPER Plus+ to their JASPER sessions. Approximately 200-300 toddlers (24-36 months) with a diagnosis of ASD, as confirmed by clinical evaluation records required for placement at the NYCIT will participate. Children will be assessed prior to intervention, immediately after Stage 1(early response) at either six or twelve weeks, exit Stage 2 intervention, and follow up.
If teacher/paraprofessional withdraws from the study, all reasonable efforts will be made to place the child with another consenting teacher/paraprofessional. Based on the first two years of trials working with this center, no teacher withdrew mid study. However, a small number of teachers did change positions or took leave (e.g., maternity leave, move for job in another district). In these cases, the child was transferred to another consenting teacher.
SMART Design:
Initial Randomize to Stage 1 Treatment
Stage 1: JASPER (6 weeks)
Early Responders/Slow Responders determined
Stage 2: JASPER (Early Responders only)-A
Slow Responders randomized to Stage 2: JASPER Plus+ + JASPER -B or Stage 2: JASPER (Randomized for slow responders)-C A, B, and C options occur during the following 18 weeks
Exit assessments and Follow up assessments at 3 months post exit
Initial Randomized to Stage 1 Treatment
Stage 1: JASPER (12 weeks)
Early Responders/Slow Responders determined
Stage 2: JASPER (Early Responders only)- D Slow Responders randomized to Stage 2: JASPER Plus+ + JASPER - E or Stage 2: JASPER (Randomized for slow responders)- F D, E, and F options occur during the following 12 weeks
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10027
- New York Center for Infants and Toddlers, Inc.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Child Inclusion Criteria:
- diagnosis of ASD based on clinical report or ADOS-2 if needed
- chronological age less than 36 months
- caregiver consent to learn intervention strategies if randomized to either parent condition.
Exclusion Criteria:
- Child has co-morbid disorders such as cerebral palsy or down syndrome.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: JASPER (6 weeks)
Child will be randomized to spend an hour daily, 5 days a week with teaching assistant (TA) doing JASPER for the following 6 weeks. If child is an early responder, he/she will continue to do JASPER daily, 5 times a week, for the remaining 18 weeks of the study. If child is a slow responder, he/she can get randomized to receive 30 minutes of JASPER Plus+ and 30 minutes of JASPER with a TA daily, 5 days a week for the remaining 18 weeks of the study. Or Child can get randomized to continue his/her daily sessions of JASPER with the TA for an hour each day, 5 days a week for the following 18 weeks of the study. |
JASPER is a developmentally anchored behavioral intervention that assumes that communication develops from social interactions in which specific social engagement strategies, symbolic representations, and early communication forms are modeled and naturally reinforced by the adult's responses to the child.
The adult referred in this condition is the TA.
JASPER Plus+ refers to direct instruction of social communication targets of pointing to share, showing gesures, and give to share gestures, and play targets at the child's target play level. JASPER Plus+ will occur at a table top with repeated trials of instruction until the child can produce the desired behavior on their own. |
|
Active Comparator: JASPER (12 weeks)
Child will be randomized to spend an hour daily, 5 days a week with teaching assistant (TA) doing JASPER for the following 12 weeks. If child is an early responder, he/she will do JASPER for 60 minutes with TA, 5 times a week, for the remaining 12 weeks of the study. If child is a slow responder, he/she can get randomized to receive 30 minutes of JASPER Plus+ and 30 minutes of JASPER with a TA daily, 5 days a week for the remaining 12 weeks of the study. Or Child can get randomized to continue his/her daily sessions of JASPER with the TA for an hour each day, 5 days a week for the following 12 weeks of the study. |
JASPER is a developmentally anchored behavioral intervention that assumes that communication develops from social interactions in which specific social engagement strategies, symbolic representations, and early communication forms are modeled and naturally reinforced by the adult's responses to the child.
The adult referred in this condition is the TA.
JASPER Plus+ refers to direct instruction of social communication targets of pointing to share, showing gesures, and give to share gestures, and play targets at the child's target play level. JASPER Plus+ will occur at a table top with repeated trials of instruction until the child can produce the desired behavior on their own. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in social communicative utterances (SCU) using Short Play and Communication Evaluation (SPACE)
Time Frame: entry (1st month of study) and 6 weeks after entry
|
The assessment is delivered in the context of play and takes approximately 15 minutes.
The change in number of socially communicative utterances (SCU) will be recorded as primary outcome.
|
entry (1st month of study) and 6 weeks after entry
|
|
Change in social communicative utterances (SCU) using Short Play and Communication Evaluation (SPACE)
Time Frame: 6 weeks after entry and 12 weeks after entry
|
The assessment is delivered in the context of play and takes approximately 15 minutes.
The change in number of socially communicative utterances (SCU) will be recorded as primary outcome.
|
6 weeks after entry and 12 weeks after entry
|
|
Change in social communicative utterances (SCU) using Short Play and Communication Evaluation (SPACE)
Time Frame: 12 weeks after entry and 24 weeks after entry
|
The assessment is delivered in the context of play and takes approximately 15 minutes.
The change in number of socially communicative utterances (SCU) will be recorded as primary outcome.
|
12 weeks after entry and 24 weeks after entry
|
|
Change in social communicative utterances (SCU) using Short Play and Communication Evaluation (SPACE)
Time Frame: 24 weeks after entry and 3 months after intervention (36 weeks)
|
The assessment is delivered in the context of play and takes approximately 15 minutes.
The change in number of socially communicative utterances (SCU) will be recorded as primary outcome.
|
24 weeks after entry and 3 months after intervention (36 weeks)
|
|
Change in social communicative utterances (SCU) using JASPER Deployment Project Treatment Fidelity Checklist (TCX)
Time Frame: entry (1st month of study) and 6 weeks after entry
|
The assessment is delivered in the context of play and takes approximately 15 minutes.
The change in number of socially communicative utterances (SCU) will be counted as the primary outcome.
|
entry (1st month of study) and 6 weeks after entry
|
|
Change in social communicative utterances (SCU) using JASPER Deployment Project Treatment Fidelity Checklist (TCX)
Time Frame: 6 weeks after entry and 12 weeks after entry
|
The assessment is delivered in the context of play and takes approximately 15 minutes.
The change in number of socially communicative utterances (SCU) will be counted as the primary outcome.
|
6 weeks after entry and 12 weeks after entry
|
|
Change in social communicative utterances (SCU) using JASPER Deployment Project Treatment Fidelity Checklist (TCX)
Time Frame: 12 weeks after entry and 24 weeks after entry
|
The assessment is delivered in the context of play and takes approximately 15 minutes.
The change in number of socially communicative utterances (SCU) will be counted as the primary outcome.
|
12 weeks after entry and 24 weeks after entry
|
|
Change in social communicative utterances (SCU) using JASPER Deployment Project Treatment Fidelity Checklist (TCX)
Time Frame: 24 weeks after entry and 3 months after intervention (36 weeks)
|
The assessment is delivered in the context of play and takes approximately 15 minutes.
The change in number of socially communicative utterances (SCU) will be counted as the primary outcome.
|
24 weeks after entry and 3 months after intervention (36 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in play levels/types using the Short Play and Communication Evaluation (SPACE)
Time Frame: entry (1st month of study) and 6 weeks after entry
|
The change in different play types and play level will be used as secondary outcome throughout the study.
|
entry (1st month of study) and 6 weeks after entry
|
|
Change in play levels/types using the Short Play and Communication Evaluation (SPACE)
Time Frame: 6 weeks after entry and 12 weeks after entry
|
The change in different play types and play level will be used as secondary outcome throughout the study.
|
6 weeks after entry and 12 weeks after entry
|
|
Change in play levels/types using the Short Play and Communication Evaluation (SPACE)
Time Frame: 12 weeks after entry and 24 weeks after entry
|
The change in different play types and play level will be used as secondary outcome throughout the study.
|
12 weeks after entry and 24 weeks after entry
|
|
Change in play levels/types using the Short Play and Communication Evaluation (SPACE)
Time Frame: 24 weeks after entry and 3 months after intervention (36 weeks)
|
The change in different play types and play level will be used as secondary outcome throughout the study.
|
24 weeks after entry and 3 months after intervention (36 weeks)
|
|
Change in joint engagement using the JASPER Deployment Project Treatment Fidelity Checklist (TCX)
Time Frame: entry (1st month of study) and 6 weeks after entry
|
The assessment is delivered in the context of play and takes approximately 15 minutes.
The change in joint engagement will be used as secondary outcome.
|
entry (1st month of study) and 6 weeks after entry
|
|
Change in joint engagement using the JASPER Deployment Project Treatment Fidelity Checklist (TCX)
Time Frame: 6 weeks after entry and 12 weeks after entry
|
The assessment is delivered in the context of play and takes approximately 15 minutes.
The change in joint engagement will be used as secondary outcome.
|
6 weeks after entry and 12 weeks after entry
|
|
Change in joint engagement using the JASPER Deployment Project Treatment Fidelity Checklist (TCX)
Time Frame: 12 weeks after entry and 24 weeks after entry
|
The assessment is delivered in the context of play and takes approximately 15 minutes.
The change in joint engagement will be used as secondary outcome.
|
12 weeks after entry and 24 weeks after entry
|
|
Change in joint engagement using the JASPER Deployment Project Treatment Fidelity Checklist (TCX)
Time Frame: 24 weeks after entry and 3 months after intervention (36 weeks)
|
The assessment is delivered in the context of play and takes approximately 15 minutes.
The change in joint engagement will be used as secondary outcome.
|
24 weeks after entry and 3 months after intervention (36 weeks)
|
Collaborators and Investigators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-000197
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Istituto Clinico HumanitasRecruitingAutism | Autism Spectrum Disorder (ASD) | Autism DisorderItaly
-
The Children's Hospital of Zhejiang University...Not yet recruitingAutism | Autism Spectrum Disorder (ASD)China
-
Poznan University of Physical EducationCompletedAutism | Autism Spectrum Disorder (ASD)Poland
-
Adia Med of Winter Park LLCActive, not recruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Poznan University of Physical EducationNational Science Centre, PolandCompletedAutism Spectrum Disorder | ASD | Autism Spectrum Disorder High-Functioning | Autism SpectrumPoland
-
Stanford UniversityJohn and Marcia Goldman FoundationNot yet recruitingAutism | Autism Spectrum Disorder (ASD)United States
-
Blinklab LimitedRecruitingAutism Spectrum Disorder | Autism | Neurodevelopmental Conditions | Autism Spectrum Disorder (ASD)United States
-
National Cheng-Kung University HospitalCompletedAutism Spectrum Disorder (ASD) | Autism Spectrum Disorder High-FunctioningTaiwan
-
University of California, Los AngelesUniversity of WashingtonRecruitingAutism Spectrum Disorder (ASD)United States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingAutism Spectrum Disorder (ASDFrance
Clinical Trials on JASPER
-
University of California, Los AngelesCompletedChildren at Risk for ASDUnited States
-
University of California, Los AngelesSimons FoundationCompletedAutism Spectrum DisorderUnited States
-
University of California, Los AngelesCompleted
-
Boston Children's HospitalCompleted
-
University of California, Los AngelesUniversity of Massachusetts, WorcesterRecruiting
-
Boston University Charles River CampusUniversity of California, Los Angeles; University of Chicago; Boston Medical... and other collaboratorsActive, not recruiting
-
Vanderbilt UniversityUniversity of California, Los AngelesCompletedDown Syndrome | Language ImpairmentUnited States
-
University of California, Los AngelesEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsUnknown
-
University of California, Los AngelesBoston Children's HospitalCompletedTuberous Sclerosis ComplexUnited States
-
University of California, Los AngelesNational Institutes of Health (NIH)Active, not recruitingAutism Spectrum DisorderUnited States